Nutrition Profess PCL
Nutrition Profess PCL is a Thai company that develops, produces, and distributes nutritional supplements and health products, primarily targeting the consumer staples and healthcare markets.
Business. Nutrition Profess PCL (NUTM.BK) is a pharmaceutical company headquartered in Thailand that operates within the Healthcare sector. The firm is primarily listed on the Stock Exchange of Thailand (SET). Specific details regarding its operating segments and geographic revenue mix are not available.
At a glance
What drives this business
The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.
News & coverage
0Sector rotation
Developing storylines
Analysis
AI analysisOpportunity
Upcoming catalysts
Scheduled public events. Informational only — not investment advice.
- Macro
- Rate decisionBank of England rate decision (press conf.)2026-08-06 · GB
- Rate decisionReserve Bank of Australia rate decision (press conf.)2026-08-12 · AU
- Rate decisionNorges Bank rate decision (press conf.)2026-08-20 · NO
- Rate decisionSveriges Riksbank rate decision (press conf.)2026-09-03 · SE
- Rate decisionBank of Canada rate decision (press conf.)2026-09-09 · CA
- Rate decisionEuropean Central Bank rate decision (press conf.)2026-09-10 · EU
- Macro & political
- ElectionSE Swedish Election2026-09-14 · SE
- ElectionUS U.S. Midterms2026-11-03 · US
- ElectionFR French Legislative2027-06-01 · FR
Pre-earnings brief
Signals & dispatch
Composite-score breakdown
Synthesis
Nutrition Profess PCL (NUTM.BK) is a pharmaceutical company headquartered in Thailand that operates within the Healthcare sector. The firm is primarily listed on the Stock Exchange of Thailand (SET). Specific details regarding its operating segments and geographic revenue mix are not available.
Nutrition Profess PCL maintains a capital structure with 120 million shares outstanding, both basic and diluted, indicating no immediate dilution pressure from share-based compensation or convertible instruments. The company reported free cash flow of 29,926,210 THB, suggesting it generates sufficient cash to support operations and potentially fund growth initiatives. However, liquidity risk could not be assessed due to the absence of balance-sheet inputs and no going-concern language in source documents.
The company's profitability is reflected in a gross profit of 253,247,900 THB and an operating income of 25,731,130 THB. While these figures indicate a healthy gross margin, the operating margin is relatively low at 8.57%, which is below the typical range for pharmaceutical and health product companies. This suggests that the company may face cost pressures or pricing constraints in its operations.
Nutrition Profess PCL operates in a single business segment focused on nutritional supplements and health products. The company's revenue is concentrated in this segment, with no disclosed geographic diversification. This concentration may expose the company to regional economic or regulatory risks, particularly in Thailand, where it is headquartered.
The company's growth trajectory is not clearly defined in the available data. No forward-looking revenue guidance or historical growth rates are provided, making it difficult to assess the company's future performance. The absence of capital expenditure data beyond a small negative value of -624,570 THB suggests limited investment in new projects or expansion.
Risk factors include the inability to assess liquidity risk due to missing balance-sheet data and the lack of going-concern language in source documents. Additionally, the company's reliance on a single business segment and geographic concentration may increase its vulnerability to market fluctuations. There is no indication of dilution pressure in the near term, as shares outstanding remain unchanged between basic and diluted counts.
Recent events and filings are not detailed in the available data. The company's 10-K or equivalent disclosures are not accessible in the provided source documents, limiting the ability to analyze recent strategic moves or financial developments.
- Nutrition Profess PCL generates strong gross profits but has a low operating margin, indicating potential cost or pricing pressures.
- The company's capital structure shows no immediate dilution risk, with basic and diluted shares outstanding being equal.
- Free cash flow is positive, suggesting the company can support operations and potentially fund growth.
- The company's business is concentrated in a single segment and geographic region, increasing exposure to local market risks.
- Liquidity risk cannot be assessed due to missing balance-sheet data and no going-concern language in source documents.
Bull / Bear case
Generated · model-assistedIn focus — financials by report
Valuation FY
Revenue by segment
Business relationships
Supply chain
Peer comparison
Market position
Stress test
Predictor forecast
Options
Short squeeze
Earnings-call key lines
Estimate revisions
consensus EPS · 26-week trendSell-side observations
Themes
ESG
Risk factors
Benchmarks vs cohort
Corporate actions / M&A
FX exposure
Comparable transactions
Derivatives & instruments
Actions
Ask Handelsavisen
- Market data
- Market data cache
- Issuer disclosures
- Public news
- Earnings transcripts
- Consensus estimates
- ESG data
- Dilution Ratio(shares_outstanding_diluted - shares_outstanding_basic) / shares_outstanding_basic
- Cash Conversion Ratiooperating_cash_flow / net_income
- Capex To Revenuecapital_expenditure / revenue
- Nutrition Profess PCL Market data — financials · 2026-05-28